Ant Group, the Alibaba-affiliated fintech giant, is utilizing a combination of Chinese and U.S.-made semiconductors to develop more efficient artificial intelligence (AI) models, according to a source familiar with the matter. This dual-source strategy not only reduces the time and cost of training AI models but also minimizes reliance on a single supplier, such as Nvidia, the global leader in AI chips.

Diversifying Chip Sources for AI Development

The source highlighted that Ant Group is adopting the "mixture of experts" (MoE) technique, an industry trend that allows AI models to be trained with significantly less computational power. By leveraging chips from both Chinese and U.S. manufacturers, Ant Group is able to optimize its AI training processes while mitigating risks associated with supply chain dependencies.

Earlier this month, Ant Group published a research paper demonstrating its ability to use lower-cost hardware to effectively train its MoE models, reducing computing costs by 20%. This approach aligns with the company’s broader strategy to enhance efficiency and scalability in its AI initiatives.

Shift from Nvidia to Alternative Chip Suppliers

While Ant Group has historically relied on Nvidia chips for AI training, the company is increasingly turning to alternatives from Advanced Micro Devices (AMD) and Chinese chipmakers, including Huawei and Alibaba’s in-house semiconductor solutions. This shift reflects the growing importance of diversifying supply chains in the face of geopolitical tensions and U.S. export restrictions on advanced semiconductors.

The U.S. government has sought to curb China’s AI development by limiting access to cutting-edge chips used for training AI models. However, Nvidia continues to sell lower-end chips to Chinese businesses, allowing companies like Ant Group to maintain some level of access to U.S. technology.

Ant Group’s AI Innovations in Healthcare

On Monday, Ant Group announced "major upgrades" to its AI solutions for healthcare, which are now being used by seven major hospitals and healthcare institutions in Beijing, Shanghai, Hangzhou, and Ningbo. The healthcare-specific AI model is built on a combination of DeepSeek’s R1 and V3 models, Alibaba’s Qwen, and Ant’s proprietary BaiLing model.

According to the company, the healthcare AI model is capable of answering medical-related questions and improving patient services. This development underscores Ant Group’s commitment to leveraging AI for practical applications that address real-world challenges.

Geopolitical Context and Industry Implications

The U.S.-China tech rivalry has significantly impacted the global semiconductor industry, with the U.S. imposing restrictions on the export of advanced chips to China. These measures aim to slow China’s progress in AI and other high-tech sectors. However, Chinese companies like Ant Group are adapting by developing in-house solutions and sourcing chips from domestic manufacturers.

Ant Group’s ability to integrate Chinese and U.S. semiconductors into its AI infrastructure highlights the resilience and adaptability of China’s tech sector. By reducing reliance on a single supplier and optimizing its AI training processes, Ant Group is positioning itself as a leader in the global AI race.

Ant Group’s dual-source semiconductor strategy represents a pragmatic approach to navigating the complexities of the global tech landscape. By combining Chinese and U.S.-made chips, the company is not only enhancing the efficiency of its AI models but also safeguarding its operations against potential supply chain disruptions. As Ant Group continues to innovate in AI and expand its applications in sectors like healthcare, its efforts underscore the importance of strategic flexibility in an increasingly competitive and geopolitically charged environment.